HOB Biotech Hits Day Low of CNY 96.50 Amid Price Pressure

HOB Biotech Group Corp. experienced a notable decline in its stock performance today, with a loss of 5.72% as of June 8, 2026. The stock reached an intraday low of CNY 96.50, reflecting ongoing challenges within the company. Over the past week, HOB Biotech has seen a significant drop of 12.25%, and its monthly performance is down by 32.29%. In the context of the broader market, the China Shanghai Composite index has only decreased by 1.7% today, highlighting the stock's underperformance. Year-to-date, HOB Biotech's shares have plummeted by 36.61%, contrasting sharply with the index's minimal decline of 0.24%. Despite a three-year performance increase of 178.41%, the company has faced difficulties, including negative results for the last three consecutive quarters. Key financial metrics indicate a challenging environment, with a return on equity of 3.56% and a price-to-book ratio of 11.74, suggesting a high valuation relative to its earnings. As HOB Biotech navigates these trends, its market position remains under scrutiny.